Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age

D.M. Burger; A.M.C. van Rossum; P.W.H. Hugen; M.H. Suur; N.G. Hartwig; S.P.M. Geelen; H.J. Scherpbier; R.M.W. Hoetelmans; A.G. Vulto; T. Berglund

Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age

Translated title of the contribution: Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age

D.M. Burger, A.M.C. van Rossum, P.W.H. Hugen, M.H. Suur, N.G. Hartwig, S.P.M. Geelen, H.J. Scherpbier, R.M.W. Hoetelmans, A.G. Vulto, T. Berglund

Integral pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age
Original language	Undefined/Unknown
Pages (from-to)	701-705
Number of pages	5
Journal	Antimicrobial Agents and Chemotherapy
Volume	45
Issue number	3
Publication status	Published - 2001

Cite this

Burger, D. M., van Rossum, A. M. C., Hugen, P. W. H., Suur, M. H., Hartwig, N. G., Geelen, S. P. M., Scherpbier, H. J., Hoetelmans, R. M. W., Vulto, A. G., & Berglund, T. (2001). Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age. Antimicrobial Agents and Chemotherapy, 45(3), 701-705.

@article{925b93e99f964d9691c7d1d74cc01a13,

title = "Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age",

author = "D.M. Burger and {van Rossum}, A.M.C. and P.W.H. Hugen and M.H. Suur and N.G. Hartwig and S.P.M. Geelen and H.J. Scherpbier and R.M.W. Hoetelmans and A.G. Vulto and T. Berglund",

year = "2001",

language = "Undefined/Unknown",

volume = "45",

pages = "701--705",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "3",

}

Burger, DM, van Rossum, AMC, Hugen, PWH, Suur, MH, Hartwig, NG, Geelen, SPM, Scherpbier, HJ, Hoetelmans, RMW, Vulto, AG & Berglund, T 2001, 'Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age', Antimicrobial Agents and Chemotherapy, vol. 45, no. 3, pp. 701-705.

Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age. / Burger, D.M.; van Rossum, A.M.C.; Hugen, P.W.H. et al.
In: Antimicrobial Agents and Chemotherapy, Vol. 45, No. 3, 2001, p. 701-705.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age

AU - Burger, D.M.

AU - van Rossum, A.M.C.

AU - Hugen, P.W.H.

AU - Suur, M.H.

AU - Hartwig, N.G.

AU - Geelen, S.P.M.

AU - Scherpbier, H.J.

AU - Hoetelmans, R.M.W.

AU - Vulto, A.G.

AU - Berglund, T.

PY - 2001

Y1 - 2001

M3 - Article

SN - 0066-4804

VL - 45

SP - 701

EP - 705

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 3

ER -